LIGAND PHARMACEUTICALS INCORPORATED Convertible Debt, Noncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Convertible Debt, Noncurrent of $0 as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2023-02-28
- 2022-12-31: Convertible Debt, Noncurrent $0.00.
- 2022-09-30: Convertible Debt, Noncurrent $0.00.
- 2022-06-30: Convertible Debt, Noncurrent $0.00.
- 2022-03-31: Convertible Debt, Noncurrent $176.54M.
| Period end | Convertible Debt, Noncurrent | Convertible Debt, Noncurrent as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $176.54M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $320.72M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $316.89M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $315.32M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $352.31M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $442.29M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $454.97M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $449.67M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $444.43M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $638.96M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $631.53M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $624.21M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $616.99M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $609.86M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $602.84M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $595.91M 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $204.65M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $0.00 10-K · filed 2016-11-14 | $201.99M 10-Q · filed 2016-05-09 |
| 2015-09-30 | $202.95M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $200.57M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $198.22M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $195.91M 10-Q · filed 2015-11-09 | |
| 2014-09-30 | $193.63M 10-Q · filed 2014-10-31 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-10-31 |